Skip to main content

Table 1 Patient characteristics of the study population

From: Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer

Characteristic Percentage (%)/Median (range)
Age (years) 61.6 (26–82)
Baseline CA-125 level (U/mL) 582 (5–24260)
Nadir CA-125 level (U/mL) 10 (3–35)
Histology
Serous 67 (69.8)
Endometrioid 10 (10.4)
Clear cell 8 (8.3)
Mucinous 4 (4.2)
Transitional 3 (3.1)
Undifferentiated 3 (3.1)
Malignant mixed müllerian tumor 1 (1.0)
Grade
Low 13 (13.5)
High 83 (86.5)
Surgical residual
<1 cm 62 (64.6)
1–2 cm 3 (3.1)
>2 cm 17 (17.7)
Unknown 14 (14.6)
FIGO stage
I 9 (9.4)
II 8 (8.3)
III 63 (65.6)
IV 14 (14.6)
Unknown 2 (2.1)
Neo-adjuvant chemotherapy 68 (70.6)
Paclitaxel-based 82 (85.4)
  1. FIGO the International Federation of Gynecology and Obstetrics.